Agile Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AGRX research report →
About the company
Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly.
- CEO
- Alfred F. Altomari
- IPO
- 2014
- Employees
- 19
- HQ
- Princeton, NJ, US
Price Chart
- Market Cap
- $10.43M
- P/E
- -0.23
- P/S
- 0.53
- P/B
- -0.20
- EV/EBITDA
- -0.79
- Div Yield
- 0.00%
- Gross Margin
- 54.18%
- Op Margin
- -101.49%
- Net Margin
- -73.83%
- ROE
- 132.32%
- ROIC
- 235.31%
- Revenue
- $19.59M · 80.02%
- Net Income
- $-14,465,000 · 43.08%
- EPS
- $-6.71 · 88.59%
- Op Income
- $-19,884,000
- FCF YoY
- 73.46%
- 52W High
- $2.63
- 52W Low
- $0.20
- 50D MA
- $1.25
- 200D MA
- $1.15
- Beta
- 1.58
- Avg Volume
- 143.29K
Get TickerSpark's AI analysis on AGRX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 26, 24 | Gilmore Geoffrey | sell | 10,125 |
| Aug 26, 24 | Gilmore Geoffrey | sell | 10,131 |
| Aug 26, 24 | Coiante Scott M | sell | 15,000 |
| Aug 26, 24 | Coiante Scott M | sell | 5,080 |
| Aug 26, 24 | Conway Robert G | sell | 10,125 |
| Aug 26, 24 | Conway Robert G | sell | 3,404 |
| Aug 26, 24 | Korner Paul | sell | 10,125 |
| Aug 26, 24 | Korner Paul | sell | 3,375 |
| Aug 26, 24 | Welsh Amy | sell | 10,125 |
| Aug 26, 24 | Welsh Amy | sell | 3,375 |
Our AGRX coverage
Recent articles, reports, and earnings notes.
No research on AGRX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AGRX report →Similar companies
Peers in the same neighborhood.